Stock Fundamentals

Company Information

Company Name
Fulgent Genetics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US3596641098
CIK: 0001674930
CUSIP: 359664109
Currency: USD
Full Time Employees: 1,315
Phone: 626 350 0537
Fiscal Year End: December
IPO Date: Sep 29, 2016
Description:

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Address:

4399 Santa Anita Avenue, El Monte, CA, United States, 91731

Directors & Officers

Name Title Year Born
Mr. Ming Hsieh Chairman & CEO 1956
Mr. Jian Xie COO & President 1966
Mr. Paul Kim CPA Chief Financial Officer 1967
Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D. Chief Scientific Officer & Lab Director 1967
Ms. Natalie Prescott CIPM, CIPP General Counsel & Chief Privacy Officer NA
Ms. Doreen Ng Vice President of Operations & Compliance NA
Mr. Jakub Sram Vice President of Business Development & Sales NA
Ms. Ellen Tsui Vice President of Human Resources NA
Mr. Brandon Perthuis Chief Commercial Officer NA
Mr. Elias Nyankojo Chief Information Security Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 02, 2025 Hanlin Gao N/A Sale 1.08K $28.33 $30.45K
Dec 02, 2025 Jian Xie N/A Sale 1.14K $28.33 $32.30K
Nov 28, 2025 Hanlin Gao N/A Sale 943.00 $29.57 $27.88K
Nov 28, 2025 Jian Xie N/A Sale 1.20K $29.57 $35.42K
Nov 24, 2025 Hanlin Gao N/A Sale 535.00 $30.47 $16.30K
Nov 24, 2025 Jian Xie N/A Sale 681.00 $30.47 $20.75K
Nov 19, 2025 Jian Xie N/A Sale 10.00K $29.10 $291.00K
Sep 03, 2025 Hanlin Gao N/A Sale 1.06K $22.03 $23.42K
Sep 03, 2025 Jian Xie N/A Sale 1.13K $22.03 $24.85K
Aug 27, 2025 Hanlin Gao N/A Sale 943.00 $21.48 $20.26K
Aug 27, 2025 Jian Xie N/A Sale 1.20K $21.48 $25.75K
Aug 25, 2025 Hanlin Gao N/A Sale 548.00 $21.50 $11.78K
Aug 25, 2025 Jian Xie N/A Sale 696.00 $21.50 $14.96K
May 27, 2025 Hanlin Gao N/A Sale 1.04K $20.54 $21.34K
May 27, 2025 Jian Xie N/A Sale 1.87K $20.54 $38.47K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.77M Mar 31, 2026 9.33% $0.00 -6.34%
RTW INVESTMENTS, LLC 1.29M Mar 31, 2026 4.33% $0.20 82.83%
Vanguard Group Inc 1.26M Dec 31, 2025 4.24% $0.00 6.85%
Acadian Asset Management LLC 1.23M Mar 31, 2026 4.15% $0.03 1,481.36%
Vanguard Capital Management, LLC 880.15K Mar 31, 2026 2.96% $0.00 0.00%
Dimensional Fund Advisors, Inc. 671.66K Mar 31, 2026 2.26% $0.00 -24.45%
Invenomic Capital Management, LP 610.32K Mar 31, 2026 2.05% $0.45 0.00%
Geode Capital Management, LLC 584.21K Mar 31, 2026 1.96% $0.00 14.95%
Ameriprise Financial Inc 563.38K Mar 31, 2026 1.89% $0.00 12.79%
State Street Corp 529.40K Mar 31, 2026 1.78% $0.00 7.24%
D. E. Shaw & Co LP 486.77K Mar 31, 2026 1.64% $0.00 -30.59%
JPMorgan Chase & Co 460.36K Mar 31, 2026 1.55% $0.00 84.05%
Millennium Management LLC 401.82K Mar 31, 2026 1.35% $0.00 -57.22%
Diametric Capital, LP 361.05K Mar 31, 2026 1.21% $1.49 80.38%
Jacobs Levy Equity Management, Inc. 356.36K Mar 31, 2026 1.20% $0.02 0.00%
Charles Schwab Investment Management Inc 354.18K Mar 31, 2026 1.19% $0.00 -12.07%
Deutsche Bank AG 325.45K Mar 31, 2026 1.09% $0.00 -25.87%
Two Sigma Investments LLC 322.19K Mar 31, 2026 1.08% $0.00 8.35%
The Goldman Sachs Group Inc 311.42K Mar 31, 2026 1.05% $0.00 -10.65%
Connor Clark & Lunn Inv Mgmt Ltd 302.56K Mar 31, 2026 1.02% $0.01 -19.28%

Shares Statistics

Shares Outstanding: 28.40M
Shares Float: 17.56M
% Insiders: 3,665.90%
% Institutions: 6,359.60%
Short % Float: 15.14%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 624.74K 2.10% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 507.74K 1.71% ▲ 0.93% May 29, 2026
3 Columbia Small Cap Value Discv A 372.38K 1.25% ▲ 0.00% Apr 30, 2026
4 Columbia Small Cap Value Discovery Fund 372.38K 1.25% ▲ 4.72% Mar 31, 2026
5 BlackRock Advantage Small Cap Core Instl 306.17K 1.03% ▲ 0.00% Apr 30, 2026
6 Xtrackers MSCI World Swap ETF 1C 302.77K 1.02% ▼ 0.63% Dec 31, 2025
7 Vanguard Institutional Extnd Mkt Idx Tr 233.94K 0.79% ▲ 0.59% Apr 30, 2026
8 Fidelity Small Cap Index 206.98K 0.70% ▲ 1.88% Mar 31, 2026
9 iShares Russell 2000 Value ETF 181.71K 0.61% ▲ 0.00% May 29, 2026
10 iShares Biotechnology ETF 145.34K 0.49% ▲ 1.96% May 29, 2026

Valuation Metrics

Enterprise Value: $326.60M
Trailing P/E: 0.00
Forward P/E: 7.70

Financial Highlights

Market Cap: $593.00M
EBITDA: $-77.20M
PEG Ratio: $1.32
Book Value: $36.39
Earnings/Share: $-2.43
Profit Margin: -23.04%
Operating Margin: -45.01%
ROA (TTM): -5.37%
ROE (TTM): -6.92%
Revenue (TTM): $320.35M
Revenue/Share (TTM): $10.40
Earnings Growth (YOY): -98.60%
Revenue Growth (YOY): -3.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.48x 0.00x 0.09x -1,214.61x -0.09x
2024-12-31 4.85x 0.00x 0.07x -434.81x -0.16x
2023-12-31 6.96x 0.01x 0.08x -400.67x -0.05x
2022-12-31 7.13x 0.02x 0.08x 176.24x 0.14x
2021-12-31 5.81x 0.02x 0.09x 16.81x 0.20x
2020-12-31 4.02x 0.03x 0.19x 819.66x 0.05x
2019-12-31 9.96x 0.01x 0.07x -0.20x 0.25x
2018-12-31 15.80x 0.00x 0.05x N/A 0.00x
2017-12-31 15.51x 0.00x 0.05x N/A 0.00x
2016-12-31 14.27x 0.00x 0.06x 0.17x 0.00x
2015-12-31 4.27x 0.00x 0.12x N/A 0.00x
2014-12-31 1.63x 0.00x 0.21x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FLGT.US!